DSIP (10 mg Vial) Dosage Protocol

TOC with Icons
Table of Contents

Quickstart Highlights

DSIP dosage protocols can help promote deep, restorative delta-wave sleep and support healthy stress response. Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (9 amino acids) first isolated from rabbit brain for its ability to enhance slow-wave sleep[1]. Research indicates DSIP may improve sleep quality, normalize sleep architecture, reduce stress-related cortisol patterns, and support mood stabilization without next-day grogginess[2][3]. This educational protocol presents a once-daily subcutaneous evening approach using a practical dilution for clear insulin-syringe measurements.

  • Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
  • Typical daily range: 100–300 mcg once daily in the evening (gradual titration).
  • Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Week

Daily Dose

Units (per injection) (mL)

Week 1

100 mcg

3 units (0.03 mL)

Week 2

150 mcg

5 units (0.05 mL)

Week 3

200 mcg

6 units (0.06 mL)

Weeks 4–8

250–300 mcg

8–9 units (0.08–0.09 mL)

Frequency: Inject once daily subcutaneously in the evening, approximately 30–60 minutes before bedtime[4]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; avoid foaming.
  3. Gently swirl/roll until dissolved (do not shake).
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Advanced / Aggressive Approach (3.0 mL = ~16.67 mg/mL)

Week

Daily Dose

Units (per injection) (mL)

Weeks 1–2

5 mg (5000 mcg)

30 units (0.30 mL)

Weeks 3–4

10 mg (10,000 mcg)

60 units (0.60 mL)

Weeks 5–8

15 mg (15,000 mcg)

90 units (0.90 mL)

Note: Advanced dosing (15–20 mg/day) is based on short‑term clinical trial protocols[4][5] for severe mitochondrial conditions and should only be pursued under medical supervision. At this concentration, doses up to 15 mg fit in a single syringe (90 units); 20 mg doses should be split into two separate subcutaneous injections at different sites. Clinical trials have not extensively evaluated SS‑31 beyond 12 weeks; extended use requires careful monitoring.

Important: This guide is for educational purposes only and is not medical advice.

Supplies Needed

Plan based on an 8–12 week nightly protocol with gradual titration.

  • Peptide Vials (DSIP, 10 mg each):

     

    • 8 weeks ≈ 1 vial (10 mg supports ~33–100 doses at 100–300 mcg)
    • 12 weeks ≈ 2 vials
  • Insulin Syringes (30- or 50-unit recommended for small volumes):

     

    • Per week: 7 syringes (1/day)
    • 8 weeks: 56 syringes
    • 12 weeks: 84 syringes
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.

     

    • 8 weeks (1 vial): 3 mL → 1 × 10 mL bottle
    • 12 weeks (2 vials): 6 mL → 1 × 10 mL bottle
  • Alcohol Swabs: One for the vial stopper + one for the injection site each day.

     

    • Per week: 14 swabs (2/day)
    • 8 weeks: 112 swabs → recommend 2 × 100-count boxes
    • 12 weeks: 168 swabs → recommend 2 × 100-count boxes

Protocol Overview

Concise summary of the once-daily evening regimen.

  • Goal: Support improved sleep quality, enhanced delta-wave (slow-wave) sleep, and stress modulation over time[2][3].
  • Schedule: Daily subcutaneous injections in the evening for 8–12 weeks.
  • Dose Range: 100–300 mcg daily with gradual titration.
  • Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested nightly titration approach.

  • Start: 100 mcg nightly; increase by ~50 mcg every 1–2 weeks as tolerated.
  • Target: 250–300 mcg nightly by Weeks 4–8.
  • Frequency: Once per day (subcutaneous), 30–60 minutes before bedtime.
  • Cycle Length: 8–12 weeks; consider a break after the cycle.
  • Timing: Evening dosing to align with natural sleep onset; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

  • Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure[5].
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); prepare aliquots if needed and avoid freeze–thaw.
  • Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes; dispose in a sharps container.
  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation[6].
  • Inject slowly; wait a few seconds before withdrawing the needle.
  • Document daily dose and site rotation to maintain consistency.
  • Avoid other sedatives during DSIP use to clearly evaluate its effects on sleep.

How This Works

DSIP acts as a neuromodulator of the sleep-wake cycle and stress response. Administration consistently increases delta-wave (slow-wave) sleep in EEG recordings[2], suggesting it promotes the initiation and maintenance of deep, non-REM sleep. DSIP readily crosses the blood-brain barrier to exert central effects[7] and may enhance inhibitory neuronal activity or modulate sleep-regulating brain regions. Additionally, DSIP attenuates ACTH and corticosterone release in response to stress, indicating an effect on the hypothalamic-pituitary-adrenal axis[8]. Unlike conventional sedatives, DSIP tends to normalize sleep architecture without next-day grogginess[3].

Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

  • Supports improved sleep quality and increased slow-wave (delta) sleep duration[2][3].
  • May help normalize disrupted sleep patterns in chronic insomnia[3].
  • Shows potential for stress reduction and mood support through HPA axis modulation[8][9].
  • Remarkably safe profile: animal studies found no lethal dose even at extremely high doses; human studies report only mild, transient side effects (occasional headache or nausea)[1][8].
  • Occasional mild injection-site reactions (redness/itch) may occur with subcutaneous administration.

Lifestyle Factors

Complementary strategies for best outcomes.

  • Maintain consistent sleep-wake schedules to reinforce circadian rhythm.
  • Limit caffeine and screen exposure in the evening hours.
  • Create a dark, cool sleep environment to support natural melatonin production.
  • Prioritize stress management techniques and regular physical activity during daytime hours.

Injection Technique

General subcutaneous guidance from clinical best-practice resources[6][10].

  • Clean the vial stopper and skin with alcohol; allow to dry.
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[6].
  • Do not aspirate for subcutaneous injections; inject slowly and steadily.
  • Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[10].
  • Using a 30- or 50-unit insulin syringe improves accuracy when measuring small volumes (3–9 units).

Recommended Source

We recommend Pure Lab Peptides for high-purity DSIP (10 mg).

Why Pure Lab Peptides?

  • High-purity, third-party-tested lots with batch COAs.
  • Consistent, ISO-aligned handling and documentation.
  • Reliable fulfillment to maintain cold-chain integrity.